Primary ovarian insufficiency (POI), also known as premature ovarian failure or premature
menopause, is defined as cessation of menstruation before the expected age of …

In this study, we aimed to determine whether anti-Müllerian hormone (AMH) levels vary
between fertile and infertile populations and compare them with basal follicle-stimulating …

Menopause is the final step in the process referred to as ovarian ageing. The age related
decrease in follicle numbers dictates the onset of cycle irregularity and the final cessation of …

Context While age-related changes in menstrual cycle length are well known, it is unclear
whether anti-Müllerian (AMH) or other ovarian reserve biomarkers have a direct association …

The term premature ovarian insufficiency (POI) describes a continuum of declining ovarian
function in a young woman, resulting in an earlier than average menopause. It is a term that …

This study assessed whether age-specific (as-) cutoffs for anti-Müllerian hormone (AMH)
have higher specificity in reflecting ovarian reserve than non-age-specific (nas-) AMH …

Anti-Müllerian hormone (AMH) in women is secreted by granulosa cells in late preantral and
small antral follicles. AMH seems to be a very stable marker having some advantages over …

Objective: The aim of this study was to assess the pattern of serum antimüllerian hormone
(AMH) across the normal ovulatory menstrual cycle in women in late reproductive age when …

This review summarizes the existing information concerning the genetic background of
menopause and primary ovarian insufficiency (POI). There is overwhelming evidence that …

Antimüllerian (AMH) has become a popular measure of ovarian reserve. The assumption is
that a single measurement of AMH has predictive value for fertility, independent of the day of …